Growth Metrics

Volitionrx (VNRX) EPS (Basic) (2019 - 2025)

Volitionrx (VNRX) has disclosed EPS (Basic) for 8 consecutive years, with -$0.07 as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, EPS (Basic) rose 45.8% year-over-year to -$0.07, compared with a TTM value of -$0.46 through Sep 2024, down 273.34%, and an annual FY2023 reading of -$0.5, down 8424.38% over the prior year.
  • EPS (Basic) was -$0.07 for Q3 2024 at Volitionrx, up from -$0.08 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.0 in Q4 2022 and bottomed at -$0.16 in Q4 2021.
  • Average EPS (Basic) over 5 years is -$0.09, with a median of -$0.11 recorded in 2020.
  • The sharpest move saw EPS (Basic) soared 101.53% in 2022, then crashed 9834.29% in 2023.
  • Year by year, EPS (Basic) stood at -$0.11 in 2020, then crashed by 45.45% to -$0.16 in 2021, then surged by 101.06% to $0.0 in 2022, then crashed by 7283.05% to -$0.12 in 2023, then skyrocketed by 45.75% to -$0.07 in 2024.
  • Business Quant data shows EPS (Basic) for VNRX at -$0.07 in Q3 2024, -$0.08 in Q2 2024, and -$0.1 in Q1 2024.